Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current Assets    
Cash $ 42,062 $ 358,303
Accounts receivable, net of allowance of $2,772 and $3,421 at September 30, 2018 and December 31, 2017, respectively 155,186 188,067
Accounts receivable - related parties, net of allowance of $514,087 at each of September 30, 2018 and December 31, 2017 137,396 851,016
Advances and loans to employees 280,776 284,496
Inventory 1,049,265 1,388,666
Real estate lots held for sale 22,267 151,906
Prepaid expenses and other current assets 174,459 159,465
Total Current Assets 1,861,411 3,381,919
Property and equipment, net 3,016,693 4,532,890
Prepaid foreign taxes, net of deferred tax reserve of $249,727 and $392,593 at September 30, 2018 and December 31, 2017, respectively 311,900 342,312
Investment - related parties 8,845 26,401
Deposits 61,284 61,284
Total Assets 5,260,133 8,344,806
Current Liabilities    
Accounts payable 529,485 415,318
Accrued expenses, current portion 807,185 1,000,521
Deferred revenue 672,292 1,732,664
Loans payable, current portion, net of debt discount 355,944 256,724
Convertible debt obligations, net of debt discount 1,557,355 20,000
Current portion of other liabilities 98,729 19,156
Total Current Liabilities 4,020,990 3,444,383
Accrued expenses, non-current portion 106,391 247,515
Other liabilities, non-current portion 11,474
Loans payable, non-current portion, net of debt discount 763,881 634,930
Total Liabilities 4,891,262 4,338,302
Commitments and Contingencies
Series B convertible redeemable preferred stock, par value $0.01 per share, 902,670 shares authorized, 902,670 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively. Liquidation preference of $9,471,781 at September 30, 2018. 9,026,824 9,026,824
Stockholders' Deficiency    
Common stock, par value $0.01 per share; 80,000,000 shares authorized; 46,738,532 and 43,067,546 shares issued and 46,687,999 and 43,063,135 shares outstanding as of September 30, 2018 and December 31, 2017, respectively. 467,384 430,674
Additional paid-in capital 83,663,629 80,902,967
Accumulated other comprehensive loss (11,991,301) (10,795,810)
Accumulated deficit (80,751,310) (75,544,081)
Treasury stock, at cost, 50,533 and 4,411 shares at September 30, 2018 and December 31, 2017, respectively. (46,355) (14,070)
Total Stockholders' Deficiency (8,657,953) (5,020,320)
Total Liabilities, Temporary Equity and Stockholders' Deficiency 5,260,133 8,344,806
Series A Convertible Preferred Stock [Member]    
Stockholders' Deficiency    
Preferred stock, 11,000,000 shares authorized; Series A convertible preferred stock, par value $0.01 per share; 10,097,330 shares authorized; no shares are available for issuance.